Testosterone is the most important androgen inthe male body. It drives muscle development, bone density, red blood cellproduction, fat distribution, libido, mood, cognitive function, and energy.It’s not an exaggeration to say that testosterone influences virtually everysystem in a man’s body.
And yet, when testosterone levels decline — asthey do in nearly every man starting around age 30 — most men don’t recognizewhat’s happening. They chalk up the fatigue to stress, the weight gain toaging, the low libido to being busy. By the time many men seek help, they’vebeen living with suboptimal testosterone for years.
Luvo’s testosterone program is designed tochange that. With three distinct medication options — testosterone replacement,Enclomiphene, and Gonadorelin — and clinical oversight from providers whospecialize in male hormone optimization, Luvo offers a personalized approachthat goes far beyond a simple testosterone prescription.
Clinically, low testosterone (hypogonadism) isgenerally defined as a total testosterone level below 300 ng/dL, though manyexperts argue that symptoms can appear at levels well above this cutoff. Thereference range for total testosterone is typically 300–1,000 ng/dL, but a manat 350 ng/dL may feel dramatically different from a man at 700 ng/dL — eventhough both are technically “normal.”
This is an important nuance that manyhealthcare providers miss. Standard medicine treats low testosterone as abinary — you’re either below 300 and qualify for treatment, or you’re above 300and told you’re fine. Luvo’s program recognizes that optimization matters.Feeling “normal” isn’t the goal — feeling your best is.
Testosterone levels decline approximately 1–2%per year after age 30. By 45, many men have lost 20–30% of their peaktestosterone. By 60, that number can exceed 40%. This gradual decline —sometimes called andropause — is a natural process, but its effects areanything but trivial.
Low testosterone manifests across physical,mental, and sexual domains, and the symptoms often develop so gradually thatmen adapt to them without realizing what’s changed.
Physical symptoms include persistent fatigueand low energy even with adequate sleep, increased body fat particularly aroundthe midsection, decreased muscle mass and strength despite regular exercise,reduced bone density, and hair thinning beyond normal male-pattern baldness.
Mental and emotional symptoms include brainfog and difficulty concentrating, irritability and mood swings, depression orpersistent low mood, reduced motivation and drive, and poor sleep quality orinsomnia.
Sexual symptoms include decreased libido,erectile dysfunction or reduced quality of erections, and reduced sexualsatisfaction.
If you’re experiencing several of thesesymptoms, declining testosterone may be a contributing factor. Luvo’s programbegins with a thorough clinical evaluation to determine whether testosteroneoptimization is appropriate for you.
Age-related decline is the most common cause,but it’s not the only factor. Several lifestyle and medical conditions can acceleratetestosterone loss.
Obesity is one of the strongest modifiablerisk factors. Fat tissue contains aromatase, an enzyme that convertstestosterone to estrogen. The more body fat you carry, the more testosteroneyou lose to conversion. This creates a vicious cycle: low testosterone promotesfat gain, and fat gain further reduces testosterone.
Chronic stress elevates cortisol, whichdirectly suppresses testosterone production. The hypothalamic-pituitary-gonadal(HPG) axis — the hormonal cascade that controls testosterone — is highlysensitive to cortisol interference.
Poor sleep is devastatingly effective atlowering testosterone. Studies show that sleeping only 5 hours per night forone week can reduce testosterone levels by 10–15%. Sleep is when the majorityof daily testosterone production occurs.
Other contributing factors include excessivealcohol consumption, certain medications including opioids and someantidepressants, metabolic syndrome and insulin resistance, and environmentalendocrine disruptors.
Luvo’s providers assess these factors duringyour consultation, because effective treatment addresses root causes alongsidehormone optimization.
What distinguishes Luvo’s testosterone programfrom competitors like Hims, Remedy Meds, or OrderlyMeds is the range oftreatment options and the clinical sophistication behind the prescribing.
Testosterone replacement therapy (TRT)directly supplements testosterone levels, restoring them to an optimal range.It’s the most direct and potent option for men with clearly low levels.
Enclomiphene is a selective estrogen receptormodulator (SERM) that stimulates the body’s own testosterone production byblocking estrogen’s negative feedback on the pituitary gland. It’s particularlyvaluable for men who want to boost testosterone while preserving fertility.
Gonadorelin is a GnRH (gonadotropin-releasinghormone) analog that maintains testicular function and fertility duringtestosterone therapy. It’s often used alongside TRT to prevent the testicularsuppression that exogenous testosterone can cause.
These three medications can be usedindividually or in strategic combinations, giving Luvo’s providers theflexibility to design a protocol tailored to your specific hormonal profile,symptoms, and life goals. Explore each option: testosterone medication,Enclomiphene, and Gonadorelin.
Here’s a scenario that plays out in men’shealth clinics every day: a man in his early 30s has symptoms of lowtestosterone. He’s fatigued, his libido is low, he’s gaining weight. He getsbloodwork, confirms his T is low, and starts testosterone replacement therapy.He feels great.
Two years later, he and his partner starttrying to have a baby. A semen analysis reveals his sperm count is near zero.He’s now facing months or years of recovery — and the possibility that hisfertility may never fully return to pre-TRT levels.
This scenario is entirely preventable. Theproblem isn’t that TRT is dangerous — it’s that most TRT protocols ignorefertility preservation from the start. Luvo’s testosterone program is builtdifferently, offering a range of approaches that let men optimize testosteroneand protect reproductive function simultaneously.
Understanding the mechanism is critical formaking informed treatment decisions.
Your hormonal system operates on feedbackloops. The hypothalamus produces GnRH, which tells the pituitary to produce LHand FSH. LH stimulates the testes to produce testosterone. FSH stimulates thetestes to produce sperm. When testosterone levels are sufficient, thehypothalamus reduces GnRH output, completing the feedback loop.
When you introduce exogenous testosterone,blood levels rise quickly to the target range. The hypothalamus detects thisand dramatically reduces GnRH output. The pituitary, receiving little GnRH,stops producing meaningful amounts of LH and FSH. Without FSH, the Sertoli cellsin the testes that support sperm development lose their stimulation. Spermproduction can decline by 90% or more.
This isn’t a rare side effect — it’s theexpected physiological response. It happens to virtually every man on TRT whodoesn’t take steps to prevent it.
For men whose primary concern is preservingfertility while addressing low testosterone, Enclomiphene offers an elegantsolution. By blocking estrogen feedback at the hypothalamus, Enclomiphene increasesGnRH, LH, and FSH — stimulating both testosterone and sperm productionsimultaneously.
This approach is particularly attractive formen in their 20s and 30s who are actively trying to conceive or expect to inthe near future, men with mild-to-moderate testosterone deficiency who mayrespond well to enhanced endogenous production, and men who want to try themost conservative approach first.
The limitation of Enclomiphene is that thedegree of testosterone elevation may be less than what TRT provides. Men withvery low baseline testosterone or primary testicular failure may not achievesufficient improvement with Enclomiphene alone.
Luvo’s providers evaluate each man’s hormonalprofile to determine whether Enclomiphene alone is likely to provide adequatetestosterone optimization.
For men who need the more robust testosteroneelevation that TRT provides but still want to protect fertility, thecombination of testosterone medication and Gonadorelin is Luvo’s recommendedapproach.
TRT raises testosterone levels reliably andsubstantially, delivering the full range of symptomatic benefits. Gonadorelin,administered alongside TRT, replaces the GnRH signal that exogenoustestosterone suppresses. This keeps the pituitary producing LH and FSH,maintaining testicular function and sperm production even in the presence ofexogenous testosterone.
This combination provides the best of bothworlds: optimal testosterone levels for symptom relief and quality of life,plus preserved reproductive capacity. It’s a protocol that requires moreclinical sophistication to manage, which is why it’s not commonly offered byhigh-volume telehealth competitors that prioritize simplicity overoptimization.
Some patients benefit from all threemedications working together. In this approach, TRT provides the primarytestosterone elevation. Gonadorelin maintains pituitary and testicularfunction. Enclomiphene provides additional endogenous stimulation and helpsmanage estrogen-related effects.
This triple protocol is the most comprehensiveoption in Luvo’s testosterone program and represents a level of hormonaloptimization that few telehealth platforms offer. It’s typically reserved formen who want maximum testosterone optimization, need robust fertilitypreservation, benefit from the estrogen-modulating effects of Enclomiphene, andare comfortable with a multi-medication protocol.
Your Luvo provider will recommend the approachthat best matches your hormonal profile, symptoms, and life goals — and willadjust the protocol over time as your needs evolve.
Explore Luvo’s testosterone medication,Enclomiphene, and Gonadorelin options, or visit the full testosterone programpage.
Testosterone replacement therapy has an imageproblem. For many people, TRT conjures images of bodybuilders, steroid abuse,and health risks. The reality is far more nuanced — and far more clinical.
TRT is a legitimate, well-studied medicaltreatment for men with clinically low or suboptimal testosterone levels. Whenproperly prescribed and monitored, it restores testosterone to physiologicallevels — not supraphysiological ones. The goal isn’t to create artificiallyelevated testosterone; it’s to restore what time and biology have taken away.
Luvo’s testosterone program offers TRT as onecomponent of a comprehensive hormone optimization approach, paired withclinical monitoring and complementary medications like Enclomiphene andGonadorelin when appropriate.
Testosterone replacement therapy introducesexogenous (externally sourced) testosterone into the body, raising bloodtestosterone levels to a target range determined by your provider. Thetestosterone used in TRT is bioidentical — chemically identical to thetestosterone your body produces naturally.
Once administered, exogenous testosteroneenters the bloodstream and binds to androgen receptors throughout the body.These receptors are found in muscle tissue (stimulating protein synthesis andmuscle growth), bone cells (supporting bone density and mineralization), thebrain (influencing mood, cognition, and motivation), fat tissue (promotinglipolysis and reducing fat storage), reproductive organs (supporting libido andsexual function), and red blood cell precursors (stimulating erythropoiesis).
The effects of TRT develop over differenttimescales. Improvements in energy, mood, and libido often appear within 3–6weeks. Body composition changes — increased muscle mass and decreased body fat— typically become noticeable over 3–6 months. Bone density improvements maytake 12 months or longer to manifest.
TRT is appropriate for men with documented lowor suboptimal testosterone levels confirmed by blood work, along with symptomsconsistent with testosterone deficiency. Ideal candidates typically include menwith total testosterone consistently below 300–400 ng/dL, men with symptoms oflow T despite levels in the low-normal range of 300–500 ng/dL, men who haveruled out or addressed reversible causes such as sleep apnea, obesity, andmedication effects, and men without contraindications including untreatedprostate cancer, severe untreated sleep apnea, or uncontrolled heart failure.
TRT is generally not recommended as afirst-line treatment for younger men who wish to preserve fertility, sinceexogenous testosterone suppresses the HPG axis and can significantly reducesperm production. For these men, Luvo offers Enclomiphene and Gonadorelin asalternatives or adjuncts.
Luvo’s providers conduct thorough bloodworkand clinical evaluation before prescribing TRT, ensuring it’s the rightintervention for your specific situation.
The benefits of properly administered TRT arewell-documented across multiple domains.
Body composition improves significantly.Meta-analyses show that TRT produces an average increase in lean body mass of3–5 pounds and a decrease in fat mass of 3–4 pounds over 6–12 months, evenwithout changes to diet or exercise. When combined with resistance training andproper nutrition, the improvements are substantially greater.
Sexual function responds reliably totestosterone optimization. Libido, erectile function, and sexual satisfactionall improve in men with low baseline testosterone. TRT doesn’t replacetreatments for ED caused by vascular or neurological factors, but when low T isa contributing cause, the improvement can be dramatic.
Mood, cognition, and energy are among theearliest and most appreciated benefits. Men frequently describe feeling likethemselves again — more motivated, more mentally sharp, and more emotionallystable. Clinical studies support reductions in depressive symptoms andimprovements in verbal memory and spatial reasoning.
Bone density increases over 12–24 months,reducing fracture risk — an increasingly important concern as men age.
Metabolic health markers often improve,including insulin sensitivity, lipid profiles, and inflammatory markers. Someresearch suggests TRT may reduce the risk of metabolic syndrome and Type 2diabetes in men with low testosterone.
TRT is not risk-free, and responsibleprescribing requires ongoing monitoring. This is where Luvo’s program differssignificantly from competitors who may offer TRT with minimal follow-up.
Erythrocytosis (elevated red blood cell count)is the most common side effect of TRT, occurring because testosteronestimulates red blood cell production. If unchecked, this can increase bloodviscosity and cardiovascular risk. Luvo monitors hematocrit levels regularlyand adjusts dosing or recommends blood donation if levels rise too high.
Testicular suppression occurs becauseexogenous testosterone signals the pituitary to reduce LH and FSH production,which can cause testicular atrophy and reduced sperm production. Luvo addressesthis proactively with Gonadorelin, which maintains gonadotropin signaling andtesticular function alongside TRT.
Estrogen conversion can occur as sometestosterone is converted to estradiol by the aromatase enzyme. Symptoms ofelevated estrogen include water retention, mood changes, and gynecomastia. Luvomonitors estradiol levels and can adjust protocols accordingly.
Regular bloodwork — including total and freetestosterone, estradiol, hematocrit, PSA, and metabolic panels — is anon-negotiable part of Luvo’s TRT program. This level of monitoring is whatseparates responsible hormone optimization from reckless prescribing.
Learn more about Luvo’s testosteronemedication and the full testosterone program.
For many men, the 40s are when theaccumulation of declining testosterone becomes impossible to ignore. Thesymptoms that were subtle in your late 30s — a little more fatigue, a littleless drive — become hard to dismiss by 42 or 45. The belly fat that resistedyour best efforts, the gym sessions that stopped producing results, the libidothat shifted from a priority to an afterthought, the mental sharpness that usedto be effortless.
Here’s the good news: this is one of the mosttreatable conditions in medicine. Testosterone optimization in men over 40 issafe, effective, and increasingly well-supported by clinical evidence. AndLuvo’s testosterone program is specifically designed to make it accessible,affordable, and clinically supervised.
By age 40, most men have experienced a 15–25%decline from their peak testosterone levels. By 50, that decline often reaches30–40%. But the numbers only tell part of the story.
SHBG (sex hormone-binding globulin) tends toincrease with age, binding more of your circulating testosterone and reducingthe free testosterone available to your tissues. This means your totaltestosterone number may underestimate the actual deficiency your body isexperiencing. A man with a total testosterone of 450 ng/dL but elevated SHBGmay have the free testosterone equivalent of someone at 300 ng/dL.
Additionally, androgen receptor sensitivitymay decline with age, meaning the same testosterone level produces lessbiological effect in a 50-year-old than a 30-year-old. Your tissues become lessresponsive to the hormone even as less of it is available.
The result is that men over 40 often feel theeffects of testosterone decline more acutely than their numbers alone wouldsuggest. This is why Luvo’s providers assess the full hormonal picture — totaltestosterone, free testosterone, SHBG, LH, FSH, and estradiol — rather than makingdecisions based on a single number.
A persistent myth in some medical circlesholds that testosterone therapy in older men is unnecessary or risky. Neitherclaim holds up under current evidence.
The TRAVERSE trial, published in the NewEngland Journal of Medicine, studied over 5,000 men aged 45–80 withhypogonadism and pre-existing cardiovascular disease or high cardiovascularrisk. The study found no increased cardiovascular risk with testosteronetherapy — directly contradicting the fears that kept many providers fromprescribing TRT to older men.
The Testosterone Trials (TTrials), acoordinated set of seven randomized controlled trials in men over 65,demonstrated that testosterone therapy improved sexual function, physicalfunction (walking distance), vitality, mood, and bone density. These benefitswere consistent and clinically meaningful.
The evidence is clear: age alone is not acontraindication to testosterone optimization. What matters is whether you havea documented deficiency, whether you have symptoms that affect your quality oflife, and whether appropriate screening and monitoring are in place.
Luvo’s program provides all three. Competitorsthat turn away men over 40 or 50 are operating on outdated science.
While the benefits of testosteroneoptimization apply across age groups, men over 40 may have specificconsiderations that influence treatment planning.
Fertility priorities shift for many men over40, but not all. Some men in their 40s and even 50s are starting new families.Luvo’s availability of Enclomiphene and Gonadorelin ensures that fertilitypreservation remains an option regardless of age.
Prostate health monitoring becomes more important.While testosterone therapy does not cause prostate cancer, pre-existingprostate conditions should be evaluated before starting treatment. Luvo’sprotocol includes baseline PSA testing and regular monitoring.
Cardiovascular risk factors are more prevalentin men over 40. Luvo’s providers screen for hypertension, dyslipidemia, andother cardiovascular risk factors, monitoring hematocrit and cardiovascularmarkers throughout treatment.
Medication interactions become more likely asmen accumulate prescriptions for other conditions. Luvo’s clinical team reviewsall current medications to avoid interactions and optimize the treatment plan.
Sleep apnea screening is important becausetestosterone therapy can theoretically worsen untreated obstructive sleep apnea.If sleep apnea is suspected, your Luvo provider will recommend evaluationbefore or alongside testosterone optimization.
Luvo’s testosterone program is designed forthe complexity that men over 40 bring to the table. Rather than a simplified,one-size-fits-all protocol, our providers create individualized treatment plansthat account for your full health picture.
The process starts with a comprehensive healthassessment and bloodwork review. Your provider will determine whether TRT,Enclomiphene, Gonadorelin, or a combination is the right approach for yourhormonal profile, symptoms, and goals.
Ongoing monitoring ensures your treatmentstays safe and effective over time, with dose adjustments and protocol refinementsbased on your response. This isn’t a set-it-and-forget-it prescription — it’san evolving clinical relationship designed to keep you at your best.
The men who thrive on Luvo’s program are thosewho approach it as a long-term investment in their health — not a quick fix.And the results — more energy, better body composition, sharper thinking,stronger libido, and improved mood — are well worth the investment.
Explore Luvo’s testosterone program to getstarted, or learn about our medication options: testosterone medication,Enclomiphene, and Gonadorelin.